Learn
Looking for more information?
Contact our responsive and friendly client services team any time.
Current price
$0.056
▾0.003 (5.08%)
Last trade: 14/10, 12:12PM
Market cap
$11.60m
Market closed
Talk to Firebrick Pharma Limited directly.
Sign up to their Investor Hub for direct access to the Firebrick Pharma Limited team, ask them questions, and see personal updates.
Investor Presentations
Principal Activity
Firebrick Pharma is an Australian pharmaceutical developer, which was founded in 2012 by Dr Peter Molloy and Dr Stephen Goodall with the mission to develop a nasal spray that killed all the germs (viruses or bacteria) responsible for respiratory infections, such as the common cold. After nearly 10 years of development and testing, their first product is now in the final stages of development and is called Nasodine® Nasal Spray*.
Website
News
Announcements
Filter
| Announcement | T+2 Movement | Date |
|---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
$0.056
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
| Company | Market Cap | ||
|---|---|---|---|
Copyright © 2024 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.
Support
Live Chat
Markets
Copyright © 2024 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.